Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2017; 9(01): 042-046
DOI: 10.4103/0974-2727.187916
Original Article

Serum Uric Acid Level in Relation to Severity of the Disease and Mortality of Critically Ill Patients

Hamed Aminiahidashti
Department of Emergency Medicine, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
,
Farzad Bozorgi
Department of Emergency Medicine, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
,
Seyed Jaber Mousavi
Department of Community Medicine, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
,
Omid Sedighi
Department of Nephrology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
,
Ali Morad Heidari Gorji
Educations and Development Center (EDC), Mazandaran University of Medical Sciences, Sari, Iran
,
Hale Rashidian
Department of Emergency Medicine, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Aim: This study was conducted to evaluate the validity of serum uric acid (UA) in prediction of mortality among patients in the emergency department.

Materials and Methods: This is a prospective cohort study which was conducted during 2014. In this study, 120 critically ill patients who required Intensive Care Unit care services were included. For evaluation of severity of the disease, mortality in emergency department score (MEDS) in the first 24 h of admission, the requirement of using mechanical ventilation, taking vasopressor during the hospitalization time and severity of the disease based on MEDS score were measured. The patients were divided into two groups: Patients with serum UA level lower than 7.3 mg/dl and patients with serum UA level of equal or more than 7.3 mg/dl. For comparison of the mortality rate in groups, Chi-square and fisher exact tests were applied.

Results: In patients, who needed mechanical ventilation, average of serum UA was 7.82 ± 2.82; however, in the patients who did not need mechanical ventilation this amount was 6.16 ± 2.7, a difference was statically significant. We found a statically meaningful difference between serum UA level with requiring mechanical ventilation and the predictive level of UA 6.95 ± 0.73 (F = 8.52; P ≤ 0.004). In the evaluation of MEDS, most patients with serum UA levels lower than 7.3 mg/dl had lower MEDS points (on average 4.6 ± 3.21) in compared to patients with serum UA level higher than 7.3 mg/dl (on average 12 ± 2.99). This difference was found to be statistically significant which indicates the patients whose serum UA was 7.3 mg/dl or higher, were at higher risk of mortality.

Conclusion: The serum UA level in the 1st day of hospitalization of a critically ill patient is not an independent indicative factor in relation to mortality. High level of UA reveals critical status of the patient and requires mechanical ventilation.

Key words

Critical ill patients - mortality - serum uric acid


Publication History

Article published online:
19 February 2020

© 2017.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002;19:640-53.
  • 2 Minguela JI, Hernando A, Gallardo I, Martínez I, Garcia P, Muñoz RI, et al. La hyperuricemia como factor de riesgo cardiovascular y renal. Dial Transplant 2011;32:57-61.
  • 3 Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S,et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-90.
  • 4 Fini MA, Elias A, Johnson RJ, Wright RM. Contribution of uric acid to cancer risk, recurrence, and mortality. Clin Transl Med 2012;1:16.
  • 5 Billiet L, Doaty S, Katz JD, Velasquez MT. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 2014;2014:852954.
  • 6 Dawson J, Jeemon P, Hetherington L, Judd C, Hastie C, Schulz C, et al. Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension 2013;62:105-11.
  • 7 Jacobs S, Zuleika M, Tariq M. Calculated total radical antioxidant potential compared in outcome groups of septic shock. Clin Intensive Care 1999;10:7-12.
  • 8 Giovannini I, Chiarla C, Giuliante F, Vellone M, Ardito F, Pallavicini F, et al. Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients. Clin Chem Lab Med 2007;45:1207-10.
  • 9 Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, et al. Uric acid and inflammatory markers. Eur Heart J 2006;27:1174-81.
  • 10 Molinos Normiella C, Rey Galán C, Medina Villanueva A, Concha Torre A, Menéndez Cuervo S. Uric acid as a prognostic marker in critically ill patients. An Esp Pediatr 2001;55:305-9.
  • 11 Riabov GA, Ladygin SS, Azizov IU. The concentration of end products of purine metabolism as possible signs of tissue hypoxia in critically ill surgical patients. Anesteziol Reanimatol 1993;4:41-3.
  • 12 Hooman N, Mehrazma M, Nakhaii S, Otukesh H, Moradi-Lakeh M, Dianati-Maleki N, et al. The value of serum uric Acid as a mortality prediction in critically ill children. Iran J Pediatr 2010;20:323-9.
  • 13 Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754-8.
  • 14 Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW. Mortality in emergency department sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule. Crit Care Med 2003;31:670-5.
  • 15 Calle P, Cerro L, Valencia J, Jaimes F. Usefulness of severity scores in patients with suspected infection in the emergency department: A systematic review. J Emerg Med 2012;42:379-91.
  • 16 Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992;268:3452-5.
  • 17 Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998;352:670-1.
  • 18 Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999;34:144-50.
  • 19 Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001;24:691-7.
  • 20 Jabs CM, Sigurdsson GH, Neglen P. Plasma levels of high-energy compounds compared with severity of illness in critically ill patients in the intensive care unit. Surgery 1998;124:65-72.
  • 21 MacKinnon KL, Molnar Z, Lowe D, Watson ID, Shearer E. Measures of total free radical activity in critically ill patients. Clin Biochem 1999;32:263-8.
  • 22 Lapsia V, Johnson RJ, Dass B, Shimada M, Kambhampati G, Ejaz NI, et al. Elevated uric acid increases the risk for acute kidney injury. Am J Med 2012;125:302.e9-17.
  • 23 Bartziokas K, Papaioannou AI, Loukides S, Papadopoulos A, Haniotou A, Papiris S, et al. Serum uric acid as a predictor of mortality and future exacerbations of COPD. Eur Respir J 2014;43:43-53.
  • 24 Christensen EF, Jacobsen J, Schultz P, Spangsberg N. Increased urinary loss of uric acid in adults with acute respiratory failure requiring mechanical ventilation. CHEST Journal 1992 1;102(2):556-9.
  • 25 Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, Shieh CC, et al. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 2006;10:R36.